HIV Persistence and the Prospect of Long-Term Drug-Free Remissions for HIV-Infected Individuals

HIV infection can persist in spite of efficacious antiretroviral therapies. Although incomplete inhibition of viral replication may contribute to this phenomenon, this is largely due to the early establishment of a stable reservoir of latently infected cells. Thus, life-long antiviral therapy may be needed to control HIV. Such therapy is prone to drug resistance and cumulative side effects and is an unbearable financial burden for regions of the world hit hardest by the epidemic. This review discusses our current understanding of HIV persistence and the limitations of potential approaches to eradicate the virus and accordingly pleads for a joint multidisciplinary effort toward two highly related goals: the development of an HIV prophylactic vaccine and the achievement of long-term drug-free remissions in HIV-infected individuals.


Published in:
Science, 329, 5988, 174-180
Year:
2010
Publisher:
American Association for the Advancement of Science
ISSN:
1095-9203
Keywords:
Laboratories:




 Record created 2010-07-20, last modified 2018-03-17


Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)